Chiesi Ventures

Traditional small molecules and biologics

Formulation technologies and devices

Disease discovery, diagnosis and management

Chiesi Ventures is unique in its focus: improving quality of diagnosis, disease management, care and therapy to all patients affected by rare diseases

We are creating a portfolio of companies focused specifically on the field of rare diseases but with complementary capabilities and missions

We believe that rare diseases accord us a great opportunity to create a  path worthy and beneficial to society

Society realizes the drama of rare diseases Chiesi Ventures want to be instrumental in funding great research and development opportunities for therapies that can provide a hope for the patients and their families

On September 2, 2014, Chiesi Ventures and Pappas Capital announced a strategic collaboration

With the deal, Chiesi Ventures is able to leverage A M Pappas & Associates’ expertise and network to access and assess deals and opportunities, lead investments and manage transactions We recognize that rare diseases are global in nature from diagnosis to clinical development To initiate a global presence and address this concern, Chiesi Ventures established offices in Italy and US to evaluate opportunities and assist companies in the US and EU

The burden of Rare Diseases